我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
34
3 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
进行中(未招募)
1
2.9%
已完成
23
67.7%
Enrolling By Invitation
尚未招募
招募中
3
8.8%
终止
撤回
2
5.9%
暂无批准数据
- ZOLL's Zenix monitor/defibrillator has received FDA premarket approval, marking the company's most clinically advanced emergency care device for EMS and hospital settings. - The device features innovative Real BVM Help and Real CPR Help technology that provides real-time clinical feedback to improve ventilation quality and CPR delivery. - Zenix combines intuitive touchscreen design with powerful functionality, allowing virtually all device functions to be accessible with three screen-touches or less. - The groundbreaking device is now available to customers in the U.S. and Canada, extending ZOLL's leadership in professional monitor/defibrillator technology.